Clinical Trial Update: Luvometinib in Pediatric SS-LCH With Special-site Single/Multifocal Bone Lesions [NA]

View source ↗

Summary

A pediatric clinical trial is evaluating Luvometinib for Langerhans Cell Histiocytosis with special-site single/multifocal bone lesions; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Langerhans Cell Histiocytosis

Drugs mentioned

• Luvometinib (Luvometinib)

Snippet

Sponsor: West China Second University Hospital | Conditions: Langerhans Cell Histiocytosis (LCH) | NA | Status: RECRUITING